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ABSTRACT 
 
Background 
Survival of children and adolescents with Fontan circulation has increased over the last 
decades, and today a large majority survive to adult age. There is increasing concern 
regarding these children’s impaired physical performance and quality of life. Little is 
known about the impact of exercise on cardiopulmonary function and quality of life in this 
patient group compared with the impact on healthy children. 
Aim 
The aims of this thesis were to study activity, physical capacity, lung function, quality of 
life, and sleep before and after an exercise intervention in patients with Fontan circulation 
and healthy matched controls. A follow-up, one year after the training programme, was also 
performed. We wanted to evaluate if physical exercise could improve cardiopulmonary 
function and also, most importantly, quality of life in this patient group. 
Method 
Patients with Fontan circulation (n = 30) and healthy controls (n = 25) performed 
measurements and/or assessments of physical activity including accelerometer recordings, 
submaximal and maximal exercise capacity, lung function, sleep, and quality of life. All 
examinations were done prior to and after an individualised endurance training programme 
for 12 weeks, and also after one year.  
Results 
Patients with Fontan circulation reported less time in regular physical exercise than healthy 
controls, though the objectively measured activity was similar. Quality of life was reported 
significantly lower by the patients and by their parents compared with the controls. After 
the exercise intervention, submaximal exercise capacity had increased and quality of life 
was improved for the patients. However, the exercise intervention did not have an impact 
on maximal exercise capacity for the patients. After one year, patients showed further 
improvement of submaximal exercise capacity and quality of life was still improved, as 
after the exercise intervention. Moreover, children with Fontan circulation had impaired 
lung function and a reduced pulmonary diffusing capacity. Diffusing capacity increased 
with age in the patients, but less than in the control subjects. Moreover, endurance training 
improved vital capacity in the patient group. Fontan patients seemed to have a prolonged 
latency to sleep onset compared with healthy children. Increased time in physical activities 
seemed to be correlated with better sleep quality in patients with Fontan circulation. 
  
Conclusions 
Structured individualized training programmes may improve submaximal exercise capacity, 
lung function, and quality of life in children with Fontan circulation. Also, the improvement 
of quality of life appears to remain, one year after the intervention. Increased amount of 
physical activity may also be beneficial for sleep quality for these patients. The clinical 
importance of our results is that increased physical activity is likely to be beneficial for 
cardiopulmonary function, quality of life, and sleep quality in this patient group. Thus, 
patients with Fontan palliation should be encouraged to regularly engage in individually 
designed sports and activities. Rehabilitation programmes should include structured 
individualised endurance training for improved outcome in this group of patients. Impaired 
health-related quality of life is most likely multifactorial and further research is needed to 
more fully understand the effects of exercise on cardiopulmonary function, sleep, and 
quality of life in this patient group. Also, more research is needed on how to individualise 
recommendations and find optimal regimens for exercise prescriptions from early age for 
these patients. The important message is, though, to encourage physical exercise for these 
patients for better health and well-being.  
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1 INTRODUCTION 
Univentricular heart is a rare and complex heart malformation. The incidence has been 
reported to be 0.39 per 1000 births (1). The survival of children with complex heart 
malformations has improved and, today, many survive to adult age (2, 3). The survival has 
improved because of developed surgical techniques over the last decades. Children with 
univentricular hearts go through repeated surgical interventions, resulting in a Fontan 
circulation (4-7). With increased survival, there is growing concern about these patients’ 
physical performance, but also about their quality of life. 
 
1.1 ANATOMY 
The children in question are born with only one functional ventricle in the heart. There are 
different underlying malformations to this condition, for example tricuspid or mitral atresia, 
underdeveloped right ventricle, underdeveloped left ventricle, a genuine single ventricle, or 
other complex heart malformations that are not possible to surgically correct to a 
biventricular circulation. Hypoplastic left heart syndrome is a rare malformation. This 
malformation is severe, with an underdeveloped left side of the heart (Fig 1). 
 
 
Figure 1. (A) Normal heart. (B) Tricuspid atresia. (C) Hypoplastic left heart syndrome (HLHS). RA 
= Right atrium; RV = Right ventricle;  LA = Left atrium; LV = Left ventricle; SVC = Superior vena 
cava; IVC = Inferior vena cava; RPA = Right pulmonary artery; LPA = Left pulmonary artery; Ao 
= Aorta. 
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1.2 THE FONTAN PROCEDURE 
The Fontan operation was first performed in 1968 in a patient with tricuspid atresia and 
described in 1971 by Fontan and Baudet (6). The procedure bears Fontan’s name, but was 
far from his only accomplishment in the field. Francis Fontan was a cardiac surgeon at the 
Department of Cardiac Surgery at the University of Bordeaux. He was very successful in 
many types of surgery for congenital heart malformations and also in heart transplantations. 
He died in January 2017 at the age of 88. 
Initially, the surgical principle was to connect the right atrium to the pulmonary artery, 
where the right atrium could act as pump for pulmonary circulation. However, this 
technique had disadvantages, with risk of thrombosis, arrhythmias, and failing pump 
function. Then, new techniques developed during the 1980s, where the superior vena cava 
was anastomosed directly to the pulmonary artery and the inferior vena cava was 
anastomosed to the pulmonary artery with a lateral tunnel technique inside the right atrium. 
The latest modification of the Fontan operation is using an extracardiac conduit between the 
inferior vena cava and the pulmonary artery; this is the established technique today (2, 7, 8) 
(Fig 2). The Fontan surgery is today a staged palliative surgery, where stage I is a palliation 
in the neonatal period depending on the hemodynamics of the defect. Stage II is the 
bidirectional Glenn procedure at the age of around six months, where the superior vena 
cava is anastomosed to the right pulmonary artery. Stage III is when the blood flow in 
inferior vena cava is directed to the pulmonary circulation by either a lateral tunnel or an 
extracardiac conduit, as described above, between the ages of two and four years (8).  
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Figure 2. The Fontan procedure with an extracardiac conduit between inferior vena cava and 
pulmonary artery. RA = Right atrium; RV = Right ventricle; LA = Left atrium; SVC = Superior 
vena cava; IVC = Inferior vena cava; RPA = Right pulmonary artery; LPA = Left pulmonary artery; 
Ao = Aorta. 
 
In the Swedish Registry of Congenital Heart Disease, Swedcon (9), there are approximately 
400 children registered as living with a total cavopulmonary connection or Fontan circulation 
in Sweden today, with approximately 100 of these children living in the Stockholm region. 
The number of adult patients, over the age of 18 years, living with a total cavopulmonary 
connection in Sweden is approximately 160, with approximately 20 of these in the 
Stockholm region, according to the registry. According to the same registry, 30 foetuses 
received a prenatal diagnosis of univentricular hearts between the years 2015–2017 in 
Stockholm, thus the yearly incidence would be around 10 foetuses. The majority of foetuses 
diagnosed with univentricular hearts led to a parental decision of abortion after repeated 
medical counselling during the pregnancy. During the years 2015–2017 there were only five 
children born with univentricular hearts in the Stockholm region according to the registry.  
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1.3 THE FONTAN PHYSIOLOGY 
In the Fontan circulation, the systemic venous return is redirected to passively perfuse the 
lungs without a pumping subpulmonary ventricle. Systemic venous pressure and pulmonary 
vascular resistance are the main determinants of pulmonary blood flow and filling of the 
ventricle. The absence of a subpulmonary pumping ventricle limits pulmonary blood flow 
and thus preload to the ventricle. Low ventricular filling and end-diastolic pressure (preload) 
may reduce cardiac output, especially in response to increased demand during exercise. A 
fenestration between the systemic veins and the atrium can increase cardiac output, but will 
lead to oxygen desaturation. Also, an increase in pressure in the systemic veins can be 
reduced to some extent by a fenestration (10). Patients with Fontan circulation and increased 
systemic venous pressure may experience serious complications like hepatic fibrosis, 
protein-losing enteropathy, or plastic bronchitis (7).  
Ventricular contractility does not seem to be the main limiting factor for cardiac output in a 
Fontan circulation, as can be the case in a biventricular circulation. During exercise, a patient 
with Fontan circulation has limited ability to increase cardiac output by reduced pulmonary 
vascular resistance and thus increased pulmonary blood flow (10-12). Also, chronotropic 
function is impaired in this patient group and the reason is probably multifactorial, including 
factors like surgical scarring and high venous pressure. This will further limit the normal 
increase in cardiac output during exercise (13). Since the Fontan circulation has limited 
preload and stroke volume reserve, an increased heart rate may not increase cardiac output as 
in a biventricular circulation. Tachycardia may actually decrease cardiac output due to a fall 
in preload of the ventricle. (14) 
Patients with Fontan circulation will have a passive pulmonary blood flow, restrictive lung 
pattern, and low cardiac output. A major determinant of cardiac output in the Fontan 
circulation is the development and resistance of the pulmonary vasculature (15, 16). The 
development of the pulmonary vasculature is not normal in Fontan patients. Many factors 
affect the development, including reduced blood flow, desaturation, collateral flow, lack of 
pulsatile flow, and absence of high blood flow and pressure during exercise. Also, the 
pulmonary circulation may have a progressive worsening over time leading to increased 
pulmonary vasculature resistance and, thus, a failing Fontan circulation (10, 13, 17, 18). 
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1.4 LONG-TERM OUTCOME 
 
In a review (2) of the Fontan operation over the last five decades, it was shown that there is a 
trend towards improved prognosis for patients with Fontan circulation, both early and long-
term. Children are surgically corrected into a Fontan circulation at a lower age, today, and 
the extracardiac total cavopulmonary anastomosis has become the most frequently used 
surgical technique internationally. Early mortality has decreased and the long-term survival 
has improved. Survival rates reported after 25 and 30 years were 83% (19) and 43% (3), 
respectively. Common causes of late mortality were ventricular failure, sudden cardiac death, 
and death after reoperation, including cardiac transplantation. The growing number of 
patients with Fontan circulation surviving into adult life will lead to more considerations 
regarding cardiac transplantations. The indication can be ventricular failure, but also 
hemodynamic failure which can be seen with protein-losing enteropathy. Risk factors for 
morbidity and mortality must be considered following cardiac transplantation and results 
vary (2). Adult patients with Fontan circulation can be expected to be in the group with 
lowest maximal oxygen uptake among adults with congenital heart diseases (20). 
A majority of the Fontan patients were reported to be in NYHA (New York Heart 
Association Functional Classification) (21) functional class I or II. Common complications 
over time were arrhythmias, thromboembolic events, and protein-losing enteropathy (2). 
Children with Fontan circulation have been reported to have reduced levels of physical 
activity (22, 23) and an exercise capacity that is approximately 60–70% of that in healthy 
children (23-26). Physical activity and exercise in the general paediatric population are 
accepted to be important preventive measures against acquired cardiovascular disease (27, 
28). This has been suggested to be even more important in patients born with congenital 
heart malformations, a group reported to be less physically active than healthy subjects (22, 
23, 29). Reduced oxygen saturation and muscle mass deficiency are other factors that may 
contribute to reduced physical capacity in Fontan patients (30). Children with Fontan 
circulation have also been shown to have impaired motor skills and flexibility compared with 
healthy children (24). Restrictions on activity or exertion by the medical profession and 
overprotection by parents may limit participation in physical activities alongside healthy 
peers (31). 
The non-pulsatile pulmonary blood flow in children with Fontan circulation might affect 
pulmonary vasculature. Also, the surgical interventions may have a negative impact on lung 
development. Studies have showed that the affected lung function in these patients was 
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correlated with an impaired exercise performance (32). It has also been reported that children 
with Fontan circulation have a lowered alveolar diffusing capacity (33-36), but more 
research is needed regarding lung function in this patient group.  
Patients with Fontan circulation might experience an affected quality of life (37). Studies 
have reported a negatively affected quality of life (37-43) and reduced exercise performance 
even in patients without severe complications during surgical procedures and medical 
follow-ups (23, 25, 26, 30). Also, it has been shown that patients with Fontan circulation 
have a lower quality of life compared with patients with less severe heart defects (38). In a 
recent study (24), it was shown that patients with Fontan circulation had decreased physical 
performance, but similar quality of life compared with healthy subjects. Atz et al. (44) have 
presented data showing that exercise performance decreased over time in survivors with 
Fontan circulation, which was associated with poorer functional health status measured using 
the Pediatric Quality of Life Inventory (PedsQL). In patients with Fontan circulation, factors 
such as the type of pumping ventricle, the number of surgical procedures and complications, 
age at completed Fontan circulation, and arrhythmia have also been reported to influence 
health-related quality of life (37). A clinical problem, raised by patients and their parents, is 
disturbed sleep and daily fatigue. In addition, long recovery time with fatigue after physical 
exercise is reported by patients and/or their parents. 
Since research has shown that exercise performance decreases over time in children with 
Fontan circulation, as well as being associated with poorer functional health status (44), this 
thesis has focused on providing these patients with an exercise intervention aiming at 
enhancing or preserving exercise capacity, but also quality of life. Other studies have been 
performed on children with Fontan circulation concerning effects of exercise. These have 
shown that exercise is safe and beneficial for physical performance among these patients (45-
47) and that exercise may be beneficial for physical performance over longer time (48). 
Exercise training may, also, have a positive effect on peripheral muscles in children with 
congenital heart disease (49). Rehabilitation programmes can also enhance physical activity 
levels in children with Fontan circulation (50). Performing exercise tests, taking part of 
exercise interventions, and seeing that physical activity is safe, is of importance for patients 
and their parents (51). Studies have reported that exercise can be beneficial for quality of life 
in patients with congenital heart disease (51-53); however, these studies had small patient 
numbers and/or lacking controls.  
Knowledge is limited about participation in sports and how exercise is perceived among 
patients with Fontan circulation. Also, not much is known regarding impact of endurance 
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exercise on physical capacity and quality of life in these patients and healthy controls. No 
published study can be found on effects of endurance training programs on lung function, 
including complete spirometry and measurements of pulmonary diffusing capacity, and also 
exercise capacity, in these patients and healthy controls. In addition, there are no available 
studies on sleep patterns in children with Fontan circulation and healthy control subjects. 
This thesis will contribute with knowledge about physical performance, lung function, sleep, 
quality of life, and impact of physical exercise in children with Fontan circulation compared 
with healthy controls. The results and possible effects on cardiopulmonary function, sleep, 
and quality of life can help healthcare providers to support patients and their parents through 
developed rehabilitation programmes that should include individually tailored physical 
exercise. 
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2 OBJECTIVES 
 
2.1 GENERAL OBJECTIVES 
  
The general objectives of this thesis were to study physical activity, physical capacity, lung 
function, quality of life, and sleep and see effects of an individualized endurance training 
programme in patients with Fontan circulation and healthy matched controls. We also 
performed a 1-year-follow-up after the training program to study long-term effects of 
physical exercise in these two groups.  
 
2.2 SPECIFIC OBJECTIVES 
 
 To compare self-reported physical exercise with objectively measured 
accelerometer activity and quality of life among children with Fontan circulation 
and healthy control subjects. (Paper I) 
 To see if an exercise intervention could improve exercise performance and quality 
of life in children with Fontan circulation, and if the effect could be long-lasting. 
(Paper II) 
 To assess lung function and see if endurance training could improve lung function 
in children with Fontan circulation compared with healthy children. (Paper III) 
 To study sleep and see if endurance training could improve sleep and sleep quality 
in children with Fontan circulation. (Paper IV) 
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3 MATERIAL 
 
We considered all children and adolescents with a Fontan circulation, born 1990-2005, in 
the Stockholm area, (N = 53), for participation in the study. Exclusion was done after 
reviewing of hospital charts (N = 13) or the families had denied joining the study (N = 10). 
Exclusion criteria were neurodevelopmental disorder (n = 5), heart transplant (n = 2), being 
under investigation for further surgery (n = 1), acute myocarditis (n = 1), muscle weakness 
(n = 1), having moved away from Stockholm region (n = 2), and height below 125 
centimeters (n = 1) (Fig 3). The included patients were to propose a healthy friend of same 
age and gender. These control subjects could not have a chronic disease in an unstable 
condition that required regular medications or be under medical investigation for 
unaddressed symptoms.  
 
 
Figure 3. Patient recruitment. Reused with permission from publisher. 
 
Our final cohort consisted of 30 patients with Fontan circulation, after parental consent and 
child assent. 17 patients proposed a friend of same age and gender, to serve as control 
subject. 13 patients did not want to ask a healthy friend to be a control subject. Therefore, 
we recruited 8 matched control subjects from families of staff at the hospital. This resulted 
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in a total of 25 healthy control subjects. Gender distribution, age, weight, height, and body 
mass index were similar between patients and controls, see Table 1. Cardiac diagnoses are 
presented in Table 1. Three patients had pacemakers with epicardial leads, as bradycardia 
protection, due to sinus node dysfunction. Anticoagulation treatment were aspirin (N = 28) 
or warfarin (N = 2). 19 patients had either enalapril or captopril prescribed. All patients had 
an extracardiac Fontan circulation that had been completed at median age 2.4 (1.1–6.4) 
years. No fenestrations were present in any patient. 
 
 
Table 1. Characteristics of patients and controls 
  
 
Patients Controls p 
Number, N 30 25 
 Male/Female, N 16/14 13/12 0.92 
Age (years) 14.2 ± 3.2 (8.9-20.4) 13.6 ± 3.5 (8.9-19.0) 0.49 
Weight (kg) 43.9 ± 11.8 (24-62) 49.1 ± 16.0 (28.0-89.0) 0.17 
Height (m) 1.53 ± 0.14 (1.28-1.78) 1.57 ± 0.16 (1.32-1.86) 0.29 
BMI (kg/m2) 18.3 ± 2.2 (14.6-24.2) 19.2 ± 3.3 (15.3-27.2) 0.22 
Cardiac diagnosis 20 hypopl right ventricle 
  
 
9 hypopl left ventricle 
  
 
1 unbalanced AVSD 
  Age at Fontan (years) 2.7 ± 1.3 (1.1-6.4) 
  Years since Fontan 11.4 ± 3.2 (6.1-16.0) 
  Values are presented as Mean ± 1SD (Min-Max) 
  AVSD: Atrio-ventricular septal defect 
  Reused with permission from publisher 
 
Poweranalysis was performed before inclusion of subjects as regards maximal oxygen 
uptake, since there were reference values available for this patient group (45). To detect a 
difference of 10% in mean value for the groups, a power of 0.92 was found with N = 35 
and a power of 0.89 was found with N = 25 (p = 0.05). The entire cohort in the Stockholm 
region was included, but a power >0.80 was reached already with N = 25 in both groups. 
Permission was not given from the Ethical Review Board at Karolinska Institutet, 
Stockholm, (Dnr 2018/128-32) to review medical charts for patients who were excluded or 
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declined participation in order to describe the representativeness of our cohort. From 
listings at the Paediatric Cardiology Department at Karolinska University Hospital in 
Stockholm, Sweden, information about some characteristics was available for these 
patients. In the group that was excluded, there were 13 patients born between 1990–2005, 
including six boys and seven girls. In the group of patients and families who declined 
participation, there were 10 patients born between 1990–2005, with equal numbers of boys 
and girls. Thus, the groups that were excluded or declined participation had even gender 
distribution and the same age range as the study participants. 
 
4 METHODS 
 
4.1 STUDY DESIGN 
Measurements of physical activity, physical capacity, lung function, sleep and quality of life 
were performed and retested after an individualized endurance training programme for twelve 
weeks. Also, a follow-up was done one year later. After the endurance training programme, 
no specific advises were given regarding continued exercise (Fig 4). All measurements were 
done similarly and with same intervals for patients and controls. 
 
 
 
 
 
 
Figure 4. Study design 
 
 
 
4.2 PHYSICAL ACTIVITY 
4.2.1 Self-reported physical exercise 
 
Subjective measures of physical activity include a variety of activity diaries, proxy reports, 
and self-administered or interviewer-based questions. A subjective self-report measure is an 
inexpensive way to assess physical activity. The limitations of self-reported measures are, for 
example, subjectivity, social desirability, and recall biases (54). 
 14 
We interviewed patients and controls separately, with respective parent/s present, regarding 
frequency, duration, and perceived intensity of organised activities and sports during an 
average week in the three months preceding the study. This included organised physical 
exercise on a regular basis every week, with an adult leader present. This information was 
included in the data as self-reported physical exercise. The types of exercise reported 
included for example physical education classes in school, swimming, horse riding, 
gymnastics and dancing. The total duration in minutes was reported, as well as the average 
perceived exertion during the activities evaluated with the Borg scale (55). The Borg scale is 
a scale from 6-20 and can be used to quantify activity efforts by a subject. The scale has been 
validated in children with and without structural heart defects (56). Thus, the interview-based 
questions in our studies allowed us to assess information about different types of regular and 
organised physical exercise with an adult leader present. The purpose of self-reported 
physical activity, where information about context and types of activities are given, made it 
therefore valuable to include in our studies.  
There is no standard questionnaire in the clinical setting on participation in physical activities 
for these patients today. An example of an instrument to measure children’s physical activity 
is the World Health Organization’s Health Behaviour in School-aged Children (HBSC) 
survey. The survey has brief questions about frequency and duration of physical activities, 
but does not include information regarding perceived exertion during the activities. It does 
not clearly indicate what type of activities should be reported; organised and/or non-
organised. Also, it has been shown that the survey has less reliability and validity in young 
children and adolescents. In addition, it has not been evaluated in a Swedish population (57). 
Another questionnaire, the International Physical Activity Questionnaire (IPAQ), has been 
shown to be difficult for children and adolescents to understand and to fail in giving reliable 
results (58). Also, IPAQ should primarily be used to evaluate physical activity at a national 
and international level and is not recommended to use for evaluating physical activity before 
exercise prescriptions and to evaluate exercise interventions for individuals (58). Thus, these 
two questionnaires did not suit our patient group or the research questions of our studies.  
 
4.2.2 Objectively measured physical activity 
Objective measurements of physical activity, with for example accelerometers, are 
recommended for children and adolescents, who have a different pattern of physical 
behaviour than adults (59). In the present studies, physical activity was therefore measured 
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objectively using accelerometers, in addition to the self-reported information regarding 
physical exercise. Actigraph GT3X accelerometers (Actigraph, Pensacola, Florida, USA) 
were used to record daily activity for seven consecutive days and nights during a regular 
school week. Triaxial accelerometers measure accelerations from three axes and give 
information about the total duration and intensity of physical activities. A faster acceleration 
results in a higher intensity and higher counts for the activity. (60, 61) 
The accelerometer was attached to the non-dominant wrist (62). After the recording period, 
the data was downloaded as 60-second epochs to the ActiLife 6 analysing software 
(Actigraph, Pensacola, Florida, USA). The total vector magnitude in counts was calculated 
from the three axes as √(axisX²+axisY²+axisZ²). The activity intensity was analysed and 
categorised in accordance with Evenson’s Actigraph cut-off points, which have been shown 
to provide the most accurate classification for all levels of physical activity intensity in 
children and adolescents. Activities were classified as sedentary (0–100 counts), light (101–
2,295 counts), moderate (2,296–4,011 counts) or vigorous (4,012 counts–above) intensity 
(63, 64). 
The seven-day monitoring with accelerometers in the study population provided reliable 
measurements of physical activity and activity patterns. It was important to include both 
weekdays and weekends, as children and adolescents have been shown to have different 
levels of activity on different days (61). The epoch length used when analysing accelerometer 
data was 60 seconds in this study. A shorter epoch length could have included more short 
episodes of moderate-vigorous intensity (60). However, when tested, there was very little 
difference in the moderate-vigorous activity recorded between different epochs of 15–60 
seconds. The time of year when the accelerometer recordings were made may also be an 
important consideration, but was the same for all patients and controls in our study. 
 
4.2.3 Endurance training programme 
Exercise training programmes, including endurance training, were constructed for all 
participants with regard to self-reported physical exercise at baseline, results from the 
cardiopulmonary exercise test, as well as season of year, the child’s own interests, and 
available sports facilities in the home environment. The idea of individually made exercise 
programmes was that it might increase compliance and, hopefully, help the child to continue 
with physical exercise at the end of the study. In addition to baseline activities, a contract was 
established between the families and the researchers to include 2 x 45 minutes of additional 
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organised endurance training every week for 12 consecutive weeks with adult leader present. 
Sutherland et al. (46) did a review of studies on effects of exercise training in patients with 
Fontan circulation and concluded that exercise programmes should be at least two months 
long with at least twice weekly training sessions in order to have positive effects on physical 
performance. Thus, with this knowledge, the exercise programmes were structured as three-
month programmes with twice weekly training sessions. 
The exercise programmes could include sports like, for example, football, swimming, horse 
riding, dancing etc. The instruction was to perform exercises at submaximal level and 
increase load during the programme. All individually designed programmes were 
documented and each child received a logbook containing the consented training programme 
at the top, and spaces below where the subject was instructed to write down every occasion of 
exercise during the exercise programme, including type of activity, duration, and intensity on 
the Borg scale (55). Also, all subjects received information to bring their logbook to the 
planned follow-up visit at the end of the training programme, in line with recommendations 
for prescription of physical activity (65). 
Individually designed training programmes where both children and parents are involved in 
deciding the type of exercise are important for higher success rate and better compliance. In 
order to design individual training programmes, information regarding type, duration, and 
intensity of the physical activities at baseline was registered. This was important since the 
included children had different exercise experiences, interests, and capacities at the time of 
inclusion in the study (65).  
4.3 EXERCISE CAPACITY 
4.3.1 Walk-test 
The participants performed a six-minute walk-test (6MWT) at the hospital. The six-minute 
walk-test is an accessible method to evaluate submaximal exercise capacity in children. The 
test has been performed by young children from four years of age with reliable results (66). 
Moreover, it is an established test for exercise capacity in children with heart conditions. The 
test reflects the subject’s ability to perform daily activities and patients with cardiac disease 
may find them easier to perform than maximal exercise tests (67). In addition, it has been 
shown that walking distance is correlated to maximal oxygen uptake in maximal 
cardiopulmonary exercise tests (67).  
It is a reliable and reproducible test to use in follow-up of functional capacity and has been 
shown to detect possible improvements after rehabilitation programmes in children with 
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congenital heart disease. In order to evaluate effects of exercise training, it is important to 
choose tests at intensities that are comparable to intensities included in the training 
programme exercises. (67) It has also been suggested that patients with Fontan circulation 
may be more limited in performing at maximal than at submaximal level (68). Thus, we 
chose to evaluate the exercise intervention with tests for both maximal and submaximal 
exercise capacities, since the training programmes and intensities differed among the 
participants. 
The participants were instructed to walk on an indoor lane as fast and far as possible during 
six minutes. Variable speed was allowed, but not running. All tests were supervised and 
structured encouragement and information regarding time left were given by study leaders. 
At the end of the test, distance that the child had walked during the six minutes was recorded. 
Heart rate was analysed before and directly after, as well as at two and four minutes after 
finishing the test. 6MWT was performed before the ergometer cycle test for maximal exercise 
capacity for each child.  
There are no available reference values on the six-minute walk-test in Swedish children and 
adolescents. In order for reliable comparisons with healthy children, similar age, weight, and 
height are important factors, since they influence the results in a six-minute walk-test (69). 
Our patient and control groups had similar age, weight, and height, as described under 
‘Material’.  
There are no previous studies available on determining minimal clinically important 
difference (70) for the six-minute walk-test in patients with Fontan circulation. The minimal 
clinically important difference represents the smallest improvement of importance for the 
patient. Also, it is used to determine the effectiveness of and satisfaction with a treatment or 
intervention, as a complement to statistically significant changes that may be of no 
importance to the health or quality of life of the patient (70). Schrover et al. (71) made a 
review of studies on minimal clinically important difference in the six-minute walk-test for 
respiratory, cardiovascular and musculoskeletal diseases. This review found a mean minimal 
clinically important difference for the six-minute walk-test of 7% change (range 3–15 %) 
using anchor-based methods, i.e., when a clinical measure is compared with a change in a 
patient-reported outcome. The minimal clinically important difference in absolute values 
ranged from 11–54 meters in the same studies. However, the concept of minimal clinically 
important difference has limitations since it can be determined in various ways (70). We 
included measurements of quality of life in our research, in order to measure effects of 
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exercise interventions on exercise capacity in relation to effects on quality of life in both 
patients and healthy controls. 
 
4.3.2 Cardiopulmonary exercise test 
All participants performed symptom-limited exercise tests with a stationary, calibrated 
upright cycle ergometer (Monark Ergomedic 839E, Monark Exercise AB, Vansbro, Sweden). 
A ramp-protocol was used, with a continuous progressive increase in load. The cycle 
ergometer was connected to a testing system (GE CASE Exercise testing system, Davis 
Medical Electronics Inc., Vista, CA, USA). The cycle ergometer was calibrated once a year 
to a known weight, in accordance with the manufacturer’s specifications. Metabolic 
variables, including oxygen uptake (VO2) and respiratory parameters, were analysed breath-
by-breath continuously (V-max®, Vyaire Medical, Mettawa, IL, USA), using a mouth-piece 
and a nose clip to prevent air leakage (Fig 5). Prior to every test, the mass flow meter was 
calibrated with a fixed volume and the gas analyser with two reference gases. 
Before starting the test, start load and continuous increase of load during the test were 
decided with regard to self-reported baseline activities and for each participant to reach 
maximal effort in ten minutes. Weight (kg) and height (m) were also included in the data. 
Echocardiography was done on all subjects, before starting the test, to identify signs of 
thrombosis, intracardiac shunting, or valvular incompetence of importance.  
During the test, the participant received instructions to perform constant pedalling with a rate 
of 60 rpm (revolutions per minute). Standard 12-lead electrocardiogram, blood pressure, and 
pulse oximetry were monitored before, during, and for ten minutes after finishing. Blood 
pressure was measured with cuff and radial artery Doppler signals. The participant was 
encouraged to continue until maximal exhaustion. Data for maximal oxygen uptake, adjusted 
for weight in kg, was analysed by averaging oxygen consumption during the last twenty 
seconds of each test (V̇O2max, ml·min
-1
·kg
-1
).  
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Figure 5. Cardiopulmonary exercise testing including measurement of maximal oxygen uptake. 
Picture used with permission from study subject. 
 
Since exercise capacity have been shown to decline over the last decades in the general 
paediatric population in Sweden (72), we chose to compare our patients’ results to a healthy 
matched control group rather than old reference materials. 
 
4.4 LUNG FUNCTION 
Spirometry, including measurements of static and dynamic volumes and flows, was done 
using body plethysmography (V-max®, Vyaire Medical, Mettawa, IL, USA) with the 
participant at rest in the sitting position. A nitrogen gas multiple breath washout study was 
also performed and the subject inhaled 100% oxygen to wash out to a nitrogen concentration 
of 1/40. Then, functional residual capacity was analysed.  
Single-breath diffusing capacity was tested with carbon monoxide. After inhalation of a test 
gas with a defined concentration of carbon monoxide, the participant held his/her breath for 
eight to ten seconds. During this time, carbon monoxide diffused over the alveolar 
membrane. Then, the participant exhaled, carbon monoxide concentration was measured and 
the diffusing capacity calculated.  
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All tests were done at least twice, until similar results were achieved, for each participant. 
Swedish reference values (73-75) were used for lung function tests. System calibrations were 
made in accordance with the manufacturer’s instructions and recommendations once a day, 
using a known volume and a known pressure in the box for static and dynamic volumes and 
capacities. Nitrogen ventilation calibration was made with two defined reference gases and 
ambient air. Calibration of diffusing capacity system was made prior to every test with a 
standardized test gas.  
 
4.5 SLEEP ANALYSIS 
Actigraph GT3X accelerometers (Actigraph, Pensacola, Florida, USA) were used for sleep-
wake scoring for seven consecutive nights during a regular school week (76, 77). The 
accelerometer was attached to the non-dominant wrist in order to improve compliance and 
also to record isolated arm movements (62, 78). After the recording period, data was 
downloaded as 60-second epochs to the ActiLife 6 analysing software (Actigraph, Pensacola, 
Florida, USA). Each participant reported ‘In Bed Time’ and ‘Out of Bed Time’ for the seven 
nights in a diary. Using algorithms developed to distinguish between sleep and wakefulness, 
analyses of accelerometer recordings could be used to determine sleep variables. The clinical 
benefit of accelerometers for sleep analysis is the possibility of performing long-term 
registrations in the individual’s own sleep environment and routines (76).  
Sleep analyses were performed using ActiLife 6 analysing software (Actigraph, Pensacola, 
Florida, USA). For sleep analyses, the algorithm developed by Sadeh et al. (79) was used. 
This algorithm has been validated and showed that sleep-wake scoring from wrist-worn 
accelerometers in healthy children and adults reached high agreement with traditional 
polysomnography for sleep periods (76). The Sadeh algorithm uses the y-axis epoch data and 
scores individual epochs as either sleep or non-sleep. ‘In Bed Time’ and ‘Out of Bed Time’ 
variables were extracted from self-reported sleep diaries for each individual as a complement 
to the accelerometer-derived analyses based on the algorithm by Sadeh et al..  
Total minutes in bed and total sleep time in minutes were analysed. Sleep efficiency (%) was 
calculated as total sleep time divided by total minutes in bed, i.e., the percentage of epochs 
categorised as asleep within the total number of epochs in bed. Total counts summarised from 
the Y-axis during sleep time were also extracted. Latency was analysed as numbers of 
minutes from ‘In Bed Time’ to sleep onset. Number of awakenings and average length of 
awakenings were analysed. If at least ten consecutive minutes were categorised as awake, the 
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sleep period ended. If an awakening was shorter, it did not interrupt the sleep period. Thus, 
even though an epoch was categorised as awake, it did not have to be an actual awakening to 
full consciousness of the subject. Wake after sleep onset was analysed and defined as the total 
number of minutes the subject was defined as awake during the sleep period. Sleep variables 
analysed are summarised in Table 2.  
 
Table 2. Sleep variables                 
In Bed Time (hh:mm) Time when subject goes to bed  
     Out of Bed Time (hh:mm) Time when subject gets out of bed 
    Total minutes in bed (min) Total minutes between 'In Bed Time' and 'Out of Bed Time' 
  Total sleep time (min) Total number of minutes scored as 'asleep' 
    Sleep efficiency (%) Number of sleep minutes divided by total numbers of minutes the subject was in bed 
Total counts night Total accelerometer counts summed together for the entire sleep period from axis Y 
Latency (min) Numbers of minutes from ‘In Bed Time’ to sleep onset 
   Awakenings (N) Number of different awakening episodes 
    Average awakening (min) Average length of all awakening episodes 
    Wake after sleep onset (min) Total number of minutes scored as 'awake' after sleep onset   
 
4.6 QUALITY OF LIFE 
Quality of life is a multidimensional concept including physical, psychological, emotional, 
and social functioning. Health-related quality of life is often used as a concept to measure 
quality of life and how it is affected by disease and treatment in patient populations. It is 
important to study quality of life as a health care outcome and to evaluate interventions (80). 
The definitions of ‘Quality of life’ and ‘Health’ from the World Health Organization are as 
follows: 
Quality of life: 
Quality of Life is an individual's perception of their position in life in the context of the 
culture and value systems in which they live and in relation to their goals, expectations, 
standards and concerns. It is a broad ranging concept affected in a complex way by the 
person's physical health, psychological state, personal beliefs, social relationships and 
their relationship to salient features of their environment. 
World Health Organization, 1997 
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Health: 
A state of complete physical, mental and social well-being, and not merely the absence 
of disease 
World Health Organization, 1948 
 
Pediatric Quality of Life Inventory Version 4.0 
Pediatric Quality of Life Inventory Version 4.0 (PedsQL) generic core scales (Mapi Research 
Trust, Lyon, France) was used to study quality of life. The PedsQL generic core scales 
consists of 8 items of physical functioning (physical domain), 5 items of emotional 
functioning, 5 items of social functioning, and 5 items of school functioning (psychosocial 
domain). Each participant and their parents answered separate questionnaires regarding the 
preceding month. The parental questionnaire assessed the parent’s perceptions of their child’s 
quality of life (parental PedsQL score). The parent forms and child forms are identical, but 
the questions in the parent forms are posed in a third-person tense. Each answer was 
transformed into a five-step score, ranging from 0-100. The total average score, as well as 
scores for the physical and psychosocial domains, were calculated. The PedsQL 4.0 
instrument is used in the national Swedish registry for congenital heart diseases (Swedcon).   
The PedsQL was originally developed for paediatric cancer patients (aged 8-18 years) as well 
as their parents, at various stages of treatment in the USA. Paediatric cancer patients served 
as the model for the development of the generic health-related quality of life measure, since 
these patients have a wide range of symptoms (81). The PedsQL was developed through 
patient and parent focus groups, interviews with experienced care providers, and review of 
available literature. It was designed to measure the core health definition by the World Health 
Organization (WHO), including role functioning, i.e. school for children. There are generic 
core scales as well as disease-specific modules, such as a cardiac module. Disease-specific 
modules may generate higher sensitivity for a chronic health condition, whereas a generic 
instrument allows comparisons between groups including healthy children (82). The PedsQL 
4.0 has shown reliability, validity, sensitivity, and responsiveness, as well as feasibility for 
quality of life assessment in children with acute or chronic health conditions and in healthy 
children over a broad age range (83).  
Research has been performed on a heterogeneous group of children (n = 915) aged 5-18 years 
and parents to children aged 2-18 years (n = 1,629) who were recruited from scheduled well-
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child checks, hospital specialty clinics, or had been seen as inpatients or outpatients at 
hospital. It showed internal consistency reliability for the total score (α = 0.88 child, 0.90 
parent), physical score (α = 0.80 child, 0.88 parent), and psychosocial score (α = 0.83 child, 
0.86 parent). Construct validity was shown and confirmed that healthy children reported 
higher scores than acutely or chronically ill children (82). Also, research has been done to 
evaluate the PedsQL 4.0 for paediatric health outcome on large cohorts and showed minimal 
missing responses, excellent reliability, and it distinguished between children with chronic 
illnesses and healthy children (84). From the age of five, children can reliably and validly 
report their quality of life with age-appropriate instruments. Also, the parent reports have 
been shown to be valid and reliable in all age groups (85). Sensitivity shows differences 
among individual patients or patient groups and responsiveness provides information about 
changes in individual patients or patient groups over time. Research has shown that PedsQL 
is sensitive to show significant differences in PedsQL scores with cardiac disease severity and 
also responsive with significant changes in PedsQL score between visits and follow-ups after 
treatments (86). 
The Swedish translation of the generic module has been studied in a general child population 
in Sweden with 1,564 children (age 8-14 years) and 634 parents. The translation was done by 
Dr Varni and the Mapi Research Institute. The generic total core scale showed internal 
consistency reliability with α = 0.90 child and α = 0.89 parent. It was also showed to be valid 
and with high agreement in test-retest on overall scores in children and parents (87). 
Minimal clinically important difference (MCID) for PedsQL scores was analysed. It was 
defined as the smallest difference in a score that patients perceive to be beneficial and that 
would mandate a change. The minimal clinically important difference was analysed by 
calculating the Standard Error of Measurement (SEM) and one SEM identified the MCID in 
responsiveness in a health-related quality of life measure. The SEM was calculated by 
multiplying the standard deviation by the square root of Cronbach alpha reliability 
coefficient. A 4.4 change in the Total Scale Score for child self-report and a 4.5 change in the 
Total Scale Score for parent proxy-report were defined as MCID by Varni et al (84). Cut-off 
points for risk of having impaired quality of life were determined by taking one standard 
deviation below the population mean (84). Scores at cut-off points represents scores similar 
to those of children with chronic diseases, e.g., children with newly diagnosed cancer report 
total score of 68.9 and children with chronic rheumatic diseases report a total score of 72.1 
(83).  
 24 
In the present studies, quality of life was evaluated using the PedsQL 4.0 generic module, in 
patients and healthy controls before and after an exercise intervention and at follow-up after 
one year. The PedsQL 4.0 generic core scale has been shown to be useful in clinical practice 
by paediatric cardiologists for a wide range of heart conditions including complex 
malformations (88). The instrument has shown validity in a large cohort of children with 
complex congenital malformations and Fontan palliation, and showed impaired quality of life 
that may worsen over time, compared with healthy subjects in the PedsQL database (43). We 
believed that the PedsQL instrument would be a suitable instrument to use because of its 
reliability, validity and responsiveness. In addition, we chose the generic rather than cardiac 
module to allow group comparisons with healthy controls.  
 
4.7 STATISTICAL ANALYSES PAPER I-IV 
The statistical program used was Statistica 12 (StatSoft Inc, Tulsa, Oklahoma, USA). 
Statistical significance was set at p < 0.05. Descriptive statistics of variables were presented 
as mean ± standard deviation (SD) when variables were normally distributed and as median 
(range) when variables were not normally distributed (Paper I-IV). 
 
T-test 
This test was used for groups to analyse normally distributed variables.  
Chi-square test 
This test was used for groups to analyse categorical variables, for example the proportion of 
males to females between the case and control group. 
Mann-Whitney U test 
This is a non-parametric test for comparing data from two groups. The test was used to 
analyse continuous data not normally distributed.  
Repeated measures ANOVA 
Repeated measures analysis of variance (ANOVA) was used to compare repeated 
measurement of the outcome variables between the groups, taken before and after the 
training programme and at follow-up after one year. 
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Multiple stepwise regression model 
Multiple regression analysis was used to examine the extent to which a dependent variable 
could be explained by a number of independent variables. The variable whose univariable 
test had a p-value < 0.05 was considered a candidate for the multivariable model. In 
selecting independent variables into the regression equation, a stepwise method was used. 
This method adds and subtracts variables until the equation contains only significant 
variables.   
Paper I 
Statistical analyses between patients and controls were made using t-tests, chi-square tests or 
Mann-Whitney tests, as appropriate. Multiple stepwise regression analysis was carried out to 
identify positive predictors of quality of life scores. Independent variables in the model were 
having a heart defect, age, gender, weight, height, self-reported physical exercise, total vector 
magnitude, and time in moderate-to-vigorous activity. 
Paper II 
Statistical analyses between patients and controls were made using t-tests, chi-square tests or 
Mann-Whitney tests, as appropriate. Repeated measures ANOVA were made for analyses 
over time. A multiple stepwise regression model was made with quality of life as a dependent 
variable and having a heart defect, distance in 6MWT, maximal oxygen uptake, maximal 
work-load, maximal heart rate, maximal blood pressure and oxygen saturation at maximal 
effort as independent variables.  
Paper III 
Statistical analyses between patients and controls were made using t-tests and chi-square 
tests, as appropriate. Repeated measures ANOVA were made for analyses over time. A 
multiple stepwise regression model was done with maximal oxygen uptake, V̇O2max, as the 
dependent variable, and gender, having a heart defect, age, weight, height, forced vital 
capacity (FVC), forced expiratory volume at the end of the first second (FEV1.0), vital 
capacity (VC), total lung capacity (TLC), residual volume (RV), and pulmonary diffusing 
capacity (DLCO) as independent variables.  
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Paper IV 
Statistical analyses between patients and controls were conducted using t-tests, Mann-
Whitney U-tests and chi-square tests, as appropriate. Repeated measures ANOVA were 
conducted for analyses over time. A multiple stepwise regression model was done with sleep 
efficiency as dependent variable, and having a heart defect, gender, age, total vector 
magnitude, and time in moderate-to-vigorous physical activity as independent variables.  
 
4.8 ETHICAL APPROVAL 
The studies were approved by the Ethical Review Board at Karolinska Institutet, Stockholm 
(Dnr 2010/84-31/4). Permission was not given from the Ethical Review Board at Karolinska 
Institutet, Stockholm (Dnr 2018/128-32), to go through medical charts for the patients who 
were excluded or who declined participation in order to describe the selection and 
representativeness of our cohort. 
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5 RESULTS 
5.1 PAPER I 
The objective of Paper I was to compare self-reported physical exercise with objectively 
measured accelerometer activity and quality of life among children with Fontan circulation 
and healthy control subjects. We found that the patients reported less time participating in 
organised physical exercise in minutes per week than controls. Also, the patients reported a 
lower average intensity for the exercise reported, than the controls (Table 3). Self-reported 
physical exercise decreased significantly with increasing age in the whole group. The self-
selected controls by the patients (n = 17) reported less time in exercise than the other controls 
(n = 8).   
 
Table 3. Self-reported physical activity and Accelerometry       
  Patient Control p Valid N 
Patient 
Valid N 
Control 
SELF-REPORTED ACTIVITY       
Physical activity, minutes per week 113.5±66.1 227.6±147.2 <0.001 30 25 
Physical activity, mean intensity in Borg 13.0±2.1 14.3±1.9 <0.05 24 25 
ACCELEROMETER       
Total vector magnitude 7 days, counts 19.2×10
6
±4.6×10
6
 18.9×10
6
±4.7×10
6
 0.79 30 25 
Sedentary % 48.6±4.4 51.8±5.2 <0.05 30 25 
Light % 41.1±3.3 38.4±3.6 <0.01 30 25 
Moderate % 10.3±4.2 9.8±3.7 0.67 30 25 
Vigorous % 0 0   30 25 
Values presented as Mean±1SD           
Reused with permission from publisher. 
 
Even though the self-reported activity differed between the groups, the objectively measured 
total vector magnitude during the seven days was similar in patients and controls (Table 3). 
Total vector magnitude was not influenced by gender or anatomical functional ventricle. A 
significant decrease in total vector magnitude was found with increasing age for patients, but 
not for controls (Fig 6).  
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Figure 6. Total vector magnitude during 7 days in counts vs. age in years in patients and controls. 
Reused with permission from publisher. 
 
Physical activity intensities, according to Evenson’s cut-off points, were analysed and are 
presented in Table 3. The patients had reduced time in sedentary activity and increased time 
in light activity compared with the controls.  
Patients and controls had similar amounts of time in moderate-to-vigorous physical activity 
(MVPA) in minutes during the seven-day recording (1,035 ± 420 minutes versus 989 ± 377 
minutes, p = 0.67). An accepted daily minimum recommendation for young people is an 
average MVPA of 60 minutes per day (27, 89). This was achieved by almost all patients and 
controls, excepting only three patients and two controls. 
 
Quality of life 
The total PedsQL scores were significantly lower for patients than controls. The parents’ 
PedsQL scores were also lower for patients than controls. Similar differences were found for 
the physical and psychosocial domains (Table 4). The PedsQL scores were not influenced by 
gender or age. The controls brought by Fontan patients had significantly lower PedsQL 
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scores than the other controls (83.4 ± 8.1 versus 90.8 ± 5.2, p < 0.05). When the results from 
the two control groups were compared with Swedish reference material (87), the self-selected 
controls by the patients had a lower PedsQL scores (p < 0.05), while the controls recruited by 
the research team had similar PedsQL scores. When analysed using a multiple stepwise 
regression model, positive predictors of quality of life were not having a heart malformation 
and more time spent in self-reported physical exercise. 
  
 
Reused with permission from publisher. 
 
5.2 PAPER II 
The objective of Paper II was to study if endurance training could improve physical 
capacity and quality of life in children after Fontan palliation, and if the effect could be 
long-lasting. 
At the second visit, only one patient had not followed the 12-week training programme. 
Furthermore, one patient and two control subjects did not want to return for the follow-up 
after one year. As described in Paper I, patients reported less time in organised physical 
exercise per week with a lower average intensity and a lower quality of life than controls at 
baseline. 
6-minute walk test 
At baseline, patients walked a significantly shorter distance in the 6MWT than the controls 
(591 ± 66 vs. 678 ± 61 meters, p < 0.001) (Table 5). Heart rate directly after six minutes of 
walking and heart rate recovery were similar in patients and controls. In a study from 
Switzerland (69), 496 healthy children and adolescents aged 5-17 years walked a mean 
Table 4. Quality of life
Patient Control p
Valid N 
Patient
Valid N 
Control
PEDSQL, score 0-100
PedsQL Children Total 70.9 ± 9.9 85.7 ± 8.0 <0.001 30 25
PedsQL Children - Physical 68.6 ± 14.2 89.6 ± 10.1 <0.001 30 25
PedsQL Children - Psychosocial 72.2 ± 9.8 83.7 ± 9.7 <0.001 30 25
PedsQL Parent Total 65.1 ± 18.0 89.2 ± 8.2 <0.001 30 24
PedsQL Parent - Physical 68.8 ± 20.5 93.8 ± 8.2 <0.001 30 25
PedsQL Parent - Psychosocial 63.2 ± 18.3 86.9 ± 9.8 <0.001 30 24
Values presented as mean ± 1SD
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distance of 618 ± 79 meters. To our knowledge, there is no available Swedish reference 
material for the 6MWT. Our healthy children walked a longer distance (p < 0.001), while our 
patients walked a similar distance (p = 0.06) compared with the Swiss reference material, but 
the mean age was lower in the Swiss reference material and comparison with reference 
material from other countries may not be valid. 
 
 
Reused with permission from publisher. 
 
Cardiopulmonary exercise testing 
All patients had sinus rhythm during the maximal exercise tests. No complications or 
arrhythmias of importance were detected in any patient. At rest, heart rate and systolic blood 
pressure were similar in patients and controls. However, oxygen saturation at rest was 
significantly lower for patients than controls (95 ± 3 % vs. 98 ± 1 %, p < 0.001). During the 
exercise tests, patients reacted with a lower increase of heart rate (p < 0.001) and a lower 
increase of blood pressure (p < 0.05) than the controls. The patients also reacted with a 
significant decrease in oxygen saturation (p < 0.001). 
At baseline, maximum work-load and maximal oxygen uptake, V̇O2max, were lower for 
patients than controls. Maximal carbon dioxide elimination, V̇CO2max, was significantly lower 
for patients than controls, while ventilatory equivalent for carbon dioxide, VE/VCO2, at 
maximal effort was significantly higher (Table 6). VE/VCO2 is a measure of the relationship 
between minute ventilation and carbon dioxide elimination. It is a measure of ventilatory 
efficiency, but has not been studied as thoroughly in paediatric populations as in adult 
populations, where a high VE/VCO2 indicates a worse prognosis (90). 
Table 5. Characteristics and Results
1. BASELINE 2. AFTER TRAINING 12 WEEKS 3. FOLLOW-UP 1 YEAR
Patients Controls p Patients Controls p Patients Controls p
Number, N 30 25 29 25 28 23
Female/male, N 14/16 12/13 0.92 13/16 12/13 0.82 12/16 11/12 0.72
Age (years) 14.2 ± 3.2 13.6 ± 3.5 0.50 14.5 ± 3.2 13.9 ± 3.5 0.53 15.1 ± 3.2 14.6 ± 3.4 0.60
Weight (kg) 43.9 ± 11.8 49.1 ± 16.0 0.17 45.4 ± 12.1 50.7 ± 16.0 0.17 47.6 ± 12.4 51.9 ± 14.5 0.26
Height (m) 1.53 ± 0.14 1.58 ± 0.16 0.29 1.54 ± 0.14 1.59 ± 0.16 0.26 1.57 ± 0.14 1.62 ± 0.15 0.29
PedsQL Child 70.9 ± 9.9 85.7 ± 8.0 <0.001 75.3 ± 9.7 87.5 ± 6.6 <0.001 74.8 ± 12.5 84.9 ± 11.2 <0.05
PedsQL Parent 65.1 ± 18.0 89.2 ± 8.2 <0.001 72.7 ± 14.6 88.2 ± 9.9 <0.001 70.2 ± 18.2 86.3 ± 14.4 <0.05
Self-reported exercise
Minutes per week 113.5 ± 66.1 227.6 ± 147.2 <0.001 168.3 ± 92.7 296.4 ± 185.3 <0.01 122.3 ± 89.7 312.3 ± 225.6 <0.001
Average intensity, Borg 13.0 ± 2.1 14.3 ± 1.9 <0.05 14.0 ± 2.0 14.6 ± 1.4 0.19 11.9 ± 5.4 14.1 ± 3.8 0.11
6MWT (m) 590.7 ± 65.5 678.1 ± 61.2 <0.001 611.8 ± 70.9 699.2 ± 65.1 <0.001 633.4 ± 75.8 688.3 ± 70.8 <0.05
Values presented as mean ± 1SD
PedsQL = Pediatric Quality of Life Inventory Version 4.0 
6MWT = 6-minute walk test
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We found that oxygen pulse, a surrogate measure of stroke volume, was significantly lower at 
maximal effort smaller in our patients than controls (9.7 ± 2.9 vs. 11.7 ± 3.8 ml·beat
-1
, p < 
0.05). Oxygen pulse is oxygen uptake, VO2, divided by heart rate and has been shown to be a 
valid estimate of stroke volume during maximal exercise in healthy adolescents (91).  
 
 
Reused with permission from publisher. 
 
 
Effects of endurance training program 
Both groups had increased weekly duration of exercise after the exercise intervention (from 
113.5 ± 66.1 to 168.3 ± 92.7 minutes per week for patients and from 227.6 ± 147.2 to 296.4 ± 
185.3 minutes per week for controls) (Table 5). After one year, patients had decreased 
duration of exercise, down to the levels before the intervention, while controls had similar 
amount of duration of exercise, as to that after the intervention. After the intervention, 
patients had increased average intensity for all activities, while the controls had similar 
average intensity throughout the study (Table 5). After one year, patients had similar intensity 
on the Borg scale as after the intervention (median Borg 14.0 (10.0–17.5) after intervention 
Table 6. Results from cardiopulmonary exercise testing at maximal effort
1. BASELINE 2. AFTER TRAINING 12 WEEKS 3. FOLLOW-UP 1 YEAR
Patients Controls p Patients Controls p Patients Controls p
HR max (beats·min-1) 166 ± 20 191 ± 10 <0.001 168 ± 20 192 ± 9 <0.001 169 ± 19 194 ± 8 <0.001
BP max (mmHg) 146 ± 14 161 ± 16 <0.001 150 ± 17 160 ± 15 <0.05 152 ± 14 160 ± 16 <0.05
Oxygen saturation at 
maximal effort (%) 91 ± 4 98 ± 1 <0.001 91 ± 4 97 ± 1 <0.001 92 ± 4 97 ± 1 <0.001
RR max 49 ± 7 49 ± 11 0,86 50 ± 10 51 ± 11 0.61 51 ± 8 52 ± 10 0.78
RER 1.05 ± 0.08 1.11 ± 0.08 <0.01 1.07 ± 0.05 1.11 ± 0.08 <0.05 1.08 ± 0.08 1.12 ± 0.08 0.12
Maximum work load 
(watts·kg-1) 2.3 ± 0.4 3.0 ± 0.7 <0.001 2.3 ± 0.4 3.1 ± 0.7 <0.001 2.3 ± 0.4 3.2 ± 0.8 <0.001
VO2max (L·min-1) 1.55 ± 0.43 2.11 ± 0.70 <0.001 1.59 ± 0.43 2.30 ± 0.79 <0.001 1.66 ± 0.49 2.36 ± 0.78 <0.001
V̇O2max (ml·min-1·kg-1) 35.0 ± 5.1 43.7 ± 8.4 <0.001 35.6 ± 6.3 45.7 ± 9.4 <0.001 35.2 ± 5.9 45.8 ± 9.9 <0.001
V̇CO2max (ml·min-1·kg-1) 36.6 ± 6.3 48.1 ± 10.2 <0.001 37.9 ± 7.1 50.3 ± 9.4 <0.001 37.8 ± 6.0 50.2 ± 8.9 <0.001
V̇Emax (L·min-1·kg-1) 1.43 ± 0.26 1.50 ± 0.34 0,44 1.48 ± 0.28 1.58 ± 0.34 0.23 1.54 ± 0.28 1.59 ± 0.33 0.56
VE/VCO2 39.0 ± 4.3 30.8 ± 3.6 <0.001 39.2 ± 4.6 31.3 ± 3.6 <0.001 40.8 ± 5.3 31.6 ± 3.9 <0.001
Values presented as mean ± 1SD
HR = Heart rate
BP = Systolic blood pressure
RR = Respiratory rate
RER = Respiratory exchange ratio
V̇O2max = Maximal oxygen uptake
V̇CO2max = Maximal elimination of carbon dioxide
VE = Minute ventilation
VE/VCO2 = Ventlatory equivalent for carbon dioxide
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vs. median Borg 14.75 (7.5–17.0) at follow-up after one year). Values in Table 5 presented as 
mean ± SD. 
6-minute walk-test 
The patients walked longer distances in a six-minute walk-test after the exercise intervention 
(p < 0.05), while the controls did not. After one year, the patients walked even longer 
distances than after the intervention (p < 0.05), while the controls still had unchanged 
distances (Table 5). Heart rate after the walk-test was similar to that before the intervention 
for patients and controls.  
Cardiopulmonary exercise testing 
After the exercise intervention, patients did not increase their maximum work-load or 
maximal oxygen uptake, V̇O2max, as the controls did (p < 0.05). After one year, both groups 
had unchanged maximum work-loads and maximal oxygen uptake, V̇O2max, as to after the 
intervention (Table 6 and Fig 7). 
 
 
Figure 7. Maximal oxygen uptake at baseline, after training, and at follow-up after one year for 
patients and controls. Reused with permission from publisher. 
 
Patients did not increase maximal elimination of carbon dioxide, V̇CO2max, after the exercise 
intervention, as the controls did (p < 0.05). Maximal minute ventilation, V̇Emax, stayed 
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unchanged for both groups troughout the study period. VE/VCO2 at maximal exhaustion 
stayed unchanged for both groups after the exercise intervention. After one year, however, 
VE/VCO2 increased for patients (p < 0.05), while the controls had similar values as after the 
intervention (p = 0.63) (Table 6).  
Oxygen pulse increased significantly after training for controls (from 11.0 ± 3.6 to 12.0 ± 4.2 
ml·beat
-1
, p < 0.05) and remained at the higher level at follow-up after one year. Our patients, 
however, did not change oxygen pulse during the study period. 
Quality of life 
Patients improved their quality of life after the exercise intervention (p < 0.01) when analysed 
with the PedsQL instrument. The improvement in the patients’ quality of life was both in the 
physical domain (p < 0.01) and the psychosocial domain (p < 0.05) of the instrument. After 
one year, the improved PedsQL score after training for the patients was sustained at a higher 
level. The controls did not report a change in quality of life throughout the entire study period 
(Table 5 and Fig 8). 
 
 
Figure 8. Quality of life scores at baseline, after training, and at follow-up after one year for patients 
and controls. Reused with permission from publisher. 
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The parental PedsQL score also increased after the exercise intervention for patients (p < 
0.001), in both the physical and psychosocial domains. This improvement was still present 
after one year. The parental PedsQL score for the controls stayed unchanged throughout the 
study period (Table 5). 
Positive predictors of quality of life were not having a heart defect (p < 0.001) and walking a 
longer distance in a 6-minute walk test (p < 0.05) in a multiple stepwise regression model. 
 
5.3 PAPER III 
The objective of Paper III was to study lung function in children with Fontan circulation 
compared with healthy children and to see if endurance training could improve lung 
function. 
Patients had a tendency to decreased forced vital capacity (FVC), forced expiratory volume in 
one second (FEV1.0), and vital capacity (VC) in absolute values, while % of predicted values 
were significantly decreased for FVC and VC compared with the controls. The two groups 
had similar values regarding total lung capacity (TLC), functional residual capacity in 
plethysmograph (FRCPL) and measured with nitrogen wash-out (FRCN2), residual volume 
(RV), and lung clearance index (LCI). Patients showed signs of trapped gas, with increased 
portion of RV to TLC compared with the controls (26 ± 6 % vs. 22 ± 5 %, p < 0.05). 
Moreover, patients had a decreased pulmonary diffusing capacity (DLCO) compared with 
controls (4.27 ± 1.16 mmol·kPa
-1
·min
-1 
vs. 6.61 ± 1.88 mmol·kPa
-1
·min
-1
, p < 0.001) (Table 
7). Diffusing capacity increased with age in both groups, but significantly less in patients than 
controls (p < 0.05) (Fig 9).  
 
 
 
 
 
 
 
 
  35 
 
Reused with permission from publisher. 
 
 
 
 
 
Table 7. Results from lung function tests at baseline
Patients Controls p
Valid N 
patients
Valid N 
controls
Dynamic spirometry
FVC, liter 2.68 ± 0.94 3.20 ± 1.02 0.055 30 25
FVC, % Ref 86 ± 17 97 ± 13 0.010 30 25
FEV1.0, liter 2.35 ± 0.68 2.79 ± 0.96 0.054 30 25
FEV1.0, % Ref 84 ± 13 90 ± 12 0.052 30 25
FEV1.0/FVC, % 90 ± 7 87 ± 7 0.154 30 25
FEF50%, l/sec 3.60 ± 0.92 3.93 ± 1.58 0.339 30 25
FEF50%, % Ref 99 ± 20 97 ± 24 0.693 30 25
FEF75%, l/sec 1.83 ± 0.58 1.99 ± 1.03 0.482 30 25
FEF75%, % Ref 97 ± 27 91 ± 32 0.497 30 25
Static spirometry
VC, liter 2.80 ± 0.97 3.37 ± 1.12 0.051 29 25
VC, % Ref 87 ± 15 97 ± 11 0.006 29 25
TLC, liter 3.81 ± 1.24 4.41 ± 1.65 0.142 27 25
TLC, % Ref 99 ± 15 104 ± 11 0.176 27 25
FRCPL, liter 1.84 ± 0.70 1.97 ± 0.68 0.522 27 25
FRCPL, % Ref 111 ± 23 106 ± 21 0.482 27 25
FRCN2, liter 1.78 ± 0.59 2.01 ± 0.72 0.193 29 25
FRCN2, % Ref 102 ± 19 109 ± 22 0.249 29 25
RV, liter 1.06 ± 0.44 1.10 ± 0.59 0.785 27 25
RV, % Ref 167 ± 57 151 ± 55 0.315 27 25
Pulmonary diffusing capacity
DLCO, mmol·kPa-1·min-1 4.27 ± 1.16 6.61 ± 1.88 < 0.001 29 25
DLCO, % Ref 60 ± 11 87 ± 10 < 0.001 29 25
LCl 5.93 ± 0.95 5.72 ± 0.59 0.339 30 25
Values are presented as Mean ± 1SD  
FVC = Forced vital capacity
FEV1.0 = Forced expiratory volume at the end of the first second
FEF50% = Forced expiratory flow at 50% of FVC exhaled
FEF75% = Forced expiratory flow at 75% of FVC exhaled
VC = Vital capacity
TLC = Total lung capacity
FRCPL = Functional residual capacity, plethysmography
FRCN2 = Functional residual capacity, N2 wash-out
RV = Residual volume
DLCO = Diffusing capacity for carbon monoxide
LCI = Lung clearance index
% Ref = Percentage of normal reference values (see Methods)
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Figure 9. Pulmonary diffusing capacity vs. age in patients and controls. Reused with permission from 
publisher. 
 
Effects of endurance training program 
Patients improved their vital capacity after the exercise intervention (p < 0.05), but the 
controls did not (p = 0.22). After one year, vital capacity had increased significantly for both 
groups (Table 8) (Fig 10).  
 
 
 
 
Table 8. Results after endurance training and at 1-year follow-up
1. BASELINE 2. AFTER TRAINING 12 WEEKS 3. 1 YEAR FOLLOW-UP
Patients Controls p Patients Controls p Patients Controls p
Number, N 30 25 29 25 28 23
Female/male, N 14/16 12/13 0.92 13/16 12/13 0.82 12/16 11/12 0.72
Age (years) 14.2 ± 3.2 13.6 ± 3.5 0.50 14.5 ± 3.2 13.9 ± 3.5 0.53 15.1 ± 3.2 14.6 ± 3.4 0.60
Weight (kg) 43.9 ± 11.8 49.1 ± 16.0 0.17 45.4 ± 12.1 50.7 ± 16.0 0.17 47.6 ± 12.4 51.9 ± 14.5 0.26
Height (m) 1.53 ± 0.14 1.58 ± 0.16 0.29 1.54 ± 0.14 1.59 ± 0.16 0.26 1.57 ± 0.14 1.62 ± 0.15 0.29
FVC (Liter) 2.68 ± 0.94 3.20 ± 1.02 0.06 2.74 ± 0.90 3.26 ± 0.98 0.05 2.94 ± 0.89 3.37 ± 0.92 0.10
FEV1.0 (Liter) 2.35 ± 0.68 2.79 ± 0.96 0.05 2.38 ± 0.68 2.79 ± 0.91 0.07 2.56 ± 0.70 2.90 ± 0.86 0.13
VC (Liter) 2.80 ± 0.97 3.37 ± 1.12 0.05 2.91 ± 0.95 3.43 ± 1.06 0.07 3.08 ± 0.95 3.56 ± 0.98 0.08
DLCO (mmol·kPa-1·min-1) 4.27 ± 1.16 6.61 ± 1.88 <0.001 4.33 ± 1.37 6.35 ± 1.89 <0.001 4.64 ± 1.49 6.89 ± 1.96 <0.001
LCI 5.93 ± 0.95 5.72 ± 0.59 0.34 5.84 ± 0.83 5.70 ± 0.58 0.50 5.87 ± 1.03 5.90 ± 0.51 0.92
Values presented as Mean ± 1SD
FVC = Forced vital capacity
FEV1.0 = Forced expiratory volume at the end of the first second
VC = Vital capacity
DLCO = Diffusing capacity for carbon monoxide
LCI = Lung clearance index
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Figure 10. Vital capacity at baseline, after training, and at follow-up after one year for patients and 
controls. Reused with permission from publisher. 
 
 
No other lung variables changed after the exercise intervention for patients or controls. After 
one year, FVC and FEV1.0 had increased significantly for both groups. Also, after one year, 
patients had similar diffusing capacity as after the interventions (p = 0.18), while the controls 
had an increased diffusing capacity compared with after the intervention (p < 0.01) (Table 8).  
We found a correlation between pulmonary diffusing capacity and maximal oxygen uptake 
(Fig 11) for all participants. Positive predictors of maximal oxygen uptake were pulmonary 
diffusing capacity (p < 0.001) and weight (p < 0.001).  
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Figure 11. Pulmonary diffusing capacity vs. maximal oxygen uptake for all study subjects. 
 
 
5.4 PAPER IV 
The objective of Paper IV was to study sleep and if endurance training could improve sleep 
and sleep quality in children after Fontan palliation. 
In Paper IV, the number of patients (n = 27) and controls (n = 22) included in analyses were 
all participants with three accepted recordings with corresponding available sleep diaries. The 
groups were comparable regarding characteristics at the three visits. The groups also had 
similar numbers of nights analysed at baseline, after training and at follow-up after one year. 
As described in Paper I, patients and controls had similar objectively measured activity. Both 
groups increased their self-reported activity after the training period, but the objectively 
measured activity was similar after training for both groups. 
Data for total minutes in bed before training were similar for patients and controls (543.9 
(424.1–636.4) minutes vs 559.8 (455.1–643.1) minutes, p = 0.71). Latency to sleep onset in 
minutes was significantly longer for patients than controls (22.4 (4.3–55.3) minutes vs. 14.8 
(8.6–29.4) minutes, p < 0.01). Other variables like total sleep time, sleep efficiency, total 
counts during sleep time, number of awakenings, length of average awakening, and wake 
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after sleep onset were similar between the groups (Table 9). No gender differences were 
found in sleep variables, in either the patient group or the control group. Total sleep time 
decreased with age in both patients (p < 0.001) and controls (p < 0.001). Sleep efficiency 
showed a tendency to decrease with age in patients (p = 0.05), but not in controls (p = 0.81).   
 
 
 
 
 
Data regarding physical activity in the daytime showed that time in moderate-to-vigorous 
physical activity was positively correlated with increased total sleep time (p < 0.05), 
improved sleep efficiency (p < 0.01) (Fig 12), and less time as wake after sleep onset during 
the sleep period (p < 0.05) for patients, but not for controls.  
 
Table 9. Results sleep analyses 
Patients Controls
N = 27 N = 22 p
Total minutes in bed (min) 543.9 (424.1 - 636.4) 559.8 (455.1 - 643.1) 0.710
Total sleep time (min) 437.1 (305.4 - 511.7) 432.7 (341.8 - 504.2) 0.880
Sleep efficiency (%) 79.4 (63.0 - 87.8) 78.4 (68.6 - 87.3) 0.740
Total counts night 60050 (32089 - 131082) 55337 (25865 - 122276) 0.817
Latency (min) 22.4 (4.3 - 55.3) 14.8 (8.6 - 29.4) 0.008
Awakenings (N) 25.4 (15.2 - 34.2) 28.1 (13.4 - 35.8) 0.191
Average awakening (min) 3.7 (2.3 - 7.1) 3.7 (2.7 - 9.6) 0.952
WASO (min) 91.4 (49.4 - 163.3) 95.1 (50.9 - 167.7) 0.527
Values are presented as median (min - max)
Values are mean values from three separate recordings
WASO = Wake after sleep onset
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Figure 12. Total sleep time in minutes and sleep efficiency (%) vs. time in moderate to vigorous 
physical activity daytime in minutes for patients and controls. 
 
Effects of endurance training program 
Patients and controls did not change their total sleep time, sleep efficiency, total 
accelerometer counts during sleep time or amount of time as wake after sleep onset after the 
training programme. However, patients with low sleep efficiency at baseline increased their 
sleep efficiency significantly (p < 0.05) after the training programme, while patients with 
higher sleep efficiency at baseline did not.  
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At follow-up after one year, patients had a decreased total sleep time, decreased sleep 
efficiency, increased total accelerometer counts during sleep time, and increased time as 
wake after sleep onset. These sleep variables were unchanged for the controls at follow-up 
after one year. Total minutes in bed and latency to sleep onset did not change during the 
whole study for patients or controls.  
In a multiple stepwise regression model for participants, positive predictors of sleep 
efficiency were female gender (p < 0.05) and time in moderate-to-vigorous physical activity 
(p < 0.01). The correlation between sleep efficiency and time in moderate-to-vigorous 
physical activity was seen in the patient group only.   
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6 DISCUSSION 
The aim of this thesis was to evaluate if physical exercise could improve cardiopulmonary 
function and also quality of life in patients with Fontan circulation. Measurements of 
physical activity, physical capacity, lung function, quality of life, and sleep were done and 
retested after an individualised endurance training programme in children with Fontan 
circulation and a healthy matched control group. Furthermore, a 1-year follow-up was 
performed in order to study long-term effects. To this day, there is little knowledge 
regarding impact of physical exercise on quality of life in this group of patients compared 
with healthy children. Since studies have reported a decline over time in physical activity 
and performance in the general paediatric population (92, 93), we considered it important to 
perform a simultaneous case and control group study. 
 
6.1 PHYSICAL ACTIVITY AND QUALITY OF LIFE (I) 
Paper I showed that patients with Fontan circulation reported less time in physical exercise 
than healthy controls. However, the overall objectively measured activity and the amount of 
time in moderate-to-vigorous activity did not differ between the patients and controls. The 
patients reported a lower quality of life than the controls.  
There was no difference between patients and controls regarding total vector magnitude, even 
though the patients had significantly shorter time spent in self-reported physical exercise by 
patients. This could be explained by the significantly shorter time in sedentary activity and 
longer time in light activity among the patients. Our results are in agreement with those of 
McCrindle et al. (23), who did not find a relationship between objectively measured and self-
reported physical activity. This may reflect a different physical behaviour, day and night, in 
patients with Fontan circulation compared with healthy children. These patients may spend 
less time in sedentary activities and less time in highly intense organised physical exercise. 
Also, there may be fewer sports offered in the society that are suited for children with special 
needs. The patients may compensate with more light forms of activity outside of organised 
exercise. Also, if these patients may choose to interact with peers who are less physically 
active than other healthy children, they may engage less in organised exercise. It was shown 
by Longmuir et al. (94) that factors associated with physical activity were primarily unrelated 
to cardiac status, for example time of year, amount of outdoor time, family income, and the 
child’s confidence in their own ability. These aspects may support our results that patients 
with Fontan circulation reported less time in organised exercise, but had the same amount of 
objectively measured activity with accelerometers. 
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The lower PedsQL scores among the patients were seen in both the physical and psychosocial 
domains of the PedsQL instrument. Furthermore, the parents’ PedsQL scores were lower for 
patients than controls. This has also been shown in other studies (40, 43). In contrast, Hock et 
al. (24) showed that children with Fontan circulation had similar health-related quality of life 
as healthy children even though they had impaired motor function and exercise capacity. 
However, the healthy controls in that study were not individually matched to the patients, 
although they were from the same geographical area. The lower PedsQL scores in our study, 
with a matched control group, may support the notion that Fontan patients should be 
encouraged to be more physically active, in order to achieve a higher quality of life (39). 
However, it cannot be excluded that a lower quality of life can result in less physical activity. 
Interventions with exercise programmes have been studied in Fontan patients and these have 
resulted in improved health-related quality of life, as shown by Dulfer et al. (52). 
Nonetheless, more research is needed to better understand functional capacity and its relation 
to quality of life in this patient group.  
The healthy peers of the patients reported less time in physical exercise, had less objectively 
measured activity, and a lower quality of life than the controls recruited by the research team. 
These observations suggest that Fontan patients tend to choose peers with lower quality of 
life and performing less physical activity than other healthy children. However, the self-
selection of controls permitted comparisons between matched groups from the same contexts 
and maybe with similar interests in physical activities.   
To summarise, our results from Paper I suggest that Fontan patients spend less time in 
organised physical activities and have a lower quality of life than healthy children. The 
objectively measured activity was, however, similar between patients and controls. 
 
6.2 PHYSICAL CAPACITY, QUALITY OF LIFE AND EFFECTS OF EXERCISE 
(II) 
Paper II showed that our patient group had a decreased physical capacity compared with 
healthy controls. Patients increased their submaximal exercise capacity and their quality of 
life after the exercise intervention. Patients did, however, not increase their maximal exercise 
capacity after the intervention. After one year, the patients had increased their submaximal 
exercise capacity even more and the quality of life was still increased as after the 
intervention. The controls increased their maximal exercise capacity after the exercise 
intervention. After one year, maximal exercise capacity was still increased as after the 
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intervention for the controls. The controls had unchanged submaximal exercise capacity and 
quality of life throughout the study period. 
Even though the patients increased amount of self-reported exercise with a higher intensity 
during the exercise intervention, they did not increased their maximal exercise capacity. This 
has also been reported by other researchers who may have had too short duration of the 
intervention (95) or too low intensity of the exercises (50). Duppen et al. (96) also studied the 
effect of exercise training and did not show an improvement in maximal oxygen uptake in 
patients with Fontan circulation. They discussed that a possible explanation for this was that a 
relatively high maximal oxygen uptake at baseline in their patients, similar to that of our 
patient group (35.0 ± 5.1 ml/min/kg at baseline), might not allow for an increase after an 
exercise intervention.  
Sutherland et al. (46) have reviewed studies on effects of exercise in patients with Fontan 
circulation and they recommend interventions to have twice weekly sessions during two 
months at least. In line with this, our exercise interventions were constructed with twice 
weekly sessions for three months. O’Byrne et al. (97) speculated if patients with Fontan 
circulations engage in exercises at a lower intensity due to exercise restrictions and that this 
could affect their ability to increase maximal exercise capacity. Our patients had a lower 
intensity of activities at baseline than controls, but did increase the intensity of activities after 
the exercise intervention. The individual programmes were constructed together with the 
child and parent/s. We considered it important to individualise the exercise interventions 
since the subjects had different interests and experiences of physical exercise at baseline, 
hoping that the children would enjoy and continue exercising after the intervention. We did 
not find a correlation between maximal exercise capacity and quality of life, in line with the 
study by O’Byrne et al. (97). Our results suggest that submaximal exercise capacity is more 
important for quality of life and, thus, well-being, rather than maximal exercise capacity. 
More studies would be useful on impact of and responses to exercise in patients with Fontan 
circulation compared with the impact and response in healthy children.  
Our training programmes consisted of endurance aerobic training. Traditionally, aerobic 
training has been the standard recommendation for exercise in children with congenital heart 
disease, rather than muscle strength training. There is not much knowledge about the effects 
of muscle strength training in children with Fontan circulation. Studies (98-100) have shown 
that adults with complex congenital heart diseases have impaired skeletal muscle function. 
Cordina et al. (98) showed, on a small number of adult Fontan patients, that isolated muscle 
training was safe and might increase cardiac filling, cardiac output, and also exercise 
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capacity. Cordina et al. (98) also showed that reduced muscle mass was correlated with 
reduced exercise performance and oxygen pulse (a surrogate for stroke volume). They 
speculated whether greater muscle mass could increase exercise capacity through an 
strengthened peripheral muscle pump. Association between the skeletal muscle pump and 
cardiac output in Fontan patients has been shown by Shafer et al. (101). More research is 
needed on muscle resistance training and its effect on children with Fontan circulation. 
Patients with Fontan circulation have a reduced ability to increase stroke volume and cardiac 
output during exercise (12). A valid estimate of stroke volume is oxygen pulse (oxygen 
uptake, VO2, divided by heart rate) and this has been shown in healthy adolescents (91). 
Healthy non-athlete adolescents have been shown to have an oxygen pulse of 13.2 ± 2.5 
ml·beat
-1
 for males and 11.0 ± 1.7 ml·beat
-1
 for females (91). We found that the oxygen pulse 
at maximal effort was significantly smaller in our patients than in controls (9.7 ± 2.9 vs. 11.7 
± 3.8 ml·beat
-1
, p < 0.05). Oxygen pulse increased after training for controls and remained at 
a higher level at follow-up after one year. However, our patients did not have changes in 
oxygen pulse during the study period. These results support that these patients have a reduced 
cardiac output during exercise and that they have a reduced ability to increase it after an 
exercise intervention. 
The patients increased their submaximal exercise capacity, measured with increased distance 
walked in a six-minute walk-test, after the exercise intervention. Banks et al. (68) have 
suggested that these patients have a more efficient peripheral oxygen extraction by the 
skeletal muscles, as a result of decreased oxygen saturation early in life. They propose that 
these patients may tolerate exercise at submaximal level better than at maximal levels. 
Patients had unchanged maximal heart rate after the walk-test, when comparing before and 
after the exercise intervention; this indicates increased peripheral effectiveness rather than 
central in response to exercise. Wittekind et al. (102) also reported increased maximal and 
submaximal exercise capacity in patients with Fontan circulation after exercise training, 
partly explained by more efficient oxygen utilization rather than central mechanisms.  
Our results showed a significant improvement of walking distance in the patient group of 4% 
and an absolute value of 21 meters. This is within range of the minimal clinically important 
difference from the review values from Schrover et al. (71), but it is difficult to draw 
conclusions from comparisons with other chronic diseases. When comparing with the control 
group in our study, the controls did not walk a significant longer distance after training 
period, which the patients did. Also, there was a corresponding improvement in quality of life 
in the patient group after training and 6MWT distance was a positive predictor of quality of 
 46 
life. This strengthens the implication and importance of physical exercise and its beneficial 
effects on quality of life in patients with Fontan circulation.      
Both groups increased exercise in minutes per week after the exercise intervention. After one 
year, however, patients decreased amount of exercise down to baseline levels. Patients had a 
lower intensity of the activities compared with the controls at baseline, as mentioned earlier. 
However, after the exercise intervention and after one year, the average intensity of activities 
did not differ between the two groups any longer. Patients might have participated in 
activities and daily life with increased intensity after the intervention. This can be the 
explanation for the improved submaximal capacity and preserved quality of life after one 
year. This may be important for these patients in their daily life. 
During maximal exercise testing, the patients reacted with a limited ability to increase heart 
rate and blood pressure, and decreasing oxygen saturation compared with the controls.  These 
patients’ limited ability to increase preload and, thus also, cardiac output during exercise 
would be the explanation for this and the reduced maximal performance. They may also lack 
experience or motivation, or fear of complications or severe symptoms, in order to perform 
activities at higher intensities.  However, the limitation in maximal heart rate response in this 
patient group may not influence submaximal exercise capacity (68).  
Other factors that may reduce exercise capacity are abnormal lung function and gas 
exchange, which has been shown in patients with Fontan circulation (32). Idorn et al. (33) 
have reported a reduced diffusing capacity and an association with a reduced capillary blood 
volume in the lungs. The decreased oxygen saturation that was seen during maximal exercise 
testing can also be explained by possible intrapulmonary shunting. This might limit alveolar 
diffusion of gas. VE/VCO2, as a measure of ventilatory efficiency, was impaired in the 
patient group, as has also been shown by Hock et al. (24). In addition, during 
cardiopulmonary exercise testing, VE/VCO2 had increased after one year only for patients, 
and not for controls. This worsening ventilator efficiency over time is of course concerning, 
but effects on the patients are unclear and more research is needed (90). The decreasing 
ventilatory efficiency and abnormal diffusing capacity in response to growth may reflect 
abnormal pulmonary vascular growth and/or gas exchange properties. One may also 
speculate whether this could be secondary to abnormal pulmonary blood flow early in life or 
a secondary effect of the non-pulsatile pulmonary hypoperfusion in the Fontan circulation. 
Efforts and interventions to maintain or even improve ventilation and lung function in these 
patients are needed.  
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Quality of life was improved after the exercise intervention, when reported by the patients 
and their parents. The healthy children and their parents reported unchanged quality of life 
after the intervention. Thus, an individualised exercise intervention may improve quality of 
life in patients with Fontan circulation and the effect may be long-lasting. This change is 
maybe not expected in a healthy group of children with a high self-reported quality of life at 
inclusion of the study.  The higher PedsQL score for the patients is greater than the minimal 
clinically important difference for the PedsQL instrument as described under ‘Methods’, 
indicating an important actual clinical effect for these patients.  
Jacobsen et al. (53) studied effects of a home-based 12-week exercise programme in 14 
patients with Fontan circulation and found improved exercise capacity and that parents, but 
not the patients themselves, reported an improved health-related quality of life. Their exercise 
programmes were identical for all subjects and included dynamic and static exercises 
presented on a DVD or paper handout. Our exercise programmes were individually based on 
the child’s performance and own interests, as described earlier. In order to achieve 
compliance, a higher quality of life, and enjoyment of activities and exercises, it might be 
important that the children themselves can choose and participate in sports and activities that 
they like. Health-related quality of life is, however, likely multifactorial and more research is 
needed to better understand effects and risk factors for impaired quality of life.    
Exercise training can improve quality of life and, thus, also daily life of patients with Fontan 
circulation. We believe that these patients should be encouraged to be physically active and 
that rehabilitation programmes should be developed and included in the medical care of these 
patients. 
 
6.3 LUNG FUNCTION AND EFFECTS OF EXERCISE (III) 
Paper III showed that children who have undergone Fontan palliation have impaired lung 
function and a tendency of restrictive lung physiology. Pulmonary diffusing capacity was 
reduced and these patients also have signs of air trapping compared with healthy controls. 
Vital capacity increased after an exercise intervention for the patients. This was not seen for 
the controls. Moreover, diffusing capacity increased with age and growth for both patients 
and controls, but significantly less in the patient group. This suggests an abnormal lung 
development with growth in the patients and/or a worsening pulmonary vasculopathy.  
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Turquetto et al. (103) have also reported restrictive lung physiology, reduced diffusing 
capacity, and an association between lung function and exercise capacity in these patients. A 
multi-center study by Opotowsky et al. (32) also showed the association between impaired 
lung function and exercise capacity. They proposed that surgical interventions might affect 
the chest wall and, thus, results in a reduced lung function and impaired lung development.  
Matthews et al. (35) also studied lung function in these patients and speculated that a reduced 
diffusing capacity might be a result of the non-pulsatile pulmonary circulation, with a 
constant flow and pressure in the vasculature. This might affect the alveolar capillary 
membranes negatively and resulting in decreased diffusing capacity. Idorn et al. (33) reported 
that diffusing capacity, in patients with Fontan circulation, increased when patients were 
lying down, horisontally. In the horisontal position, they report that pulmonary capillary 
blood volume increases for patients with a non-pulsatile flow through the lungs, and this 
results in an increased diffusing capacity. Yin et al. (104) reported a redistribution of 
pulmonary blood flow in children with Fontan circulation with, for example an increased 
blood flow to lower lung segments compared with upper lung segments. This might be the 
cause of the reduced diffusing capacity. Mettauer et al. (105) presented lung function, with a 
restrictive lung physiology and reduced diffusing capacity, in adults with chronic heart 
failure. They speculated that the impaired lung function could be a result of permanent 
vascular changes of the pulmonary vasculature, related to duration and severity of heart 
failure. One can see possible similarities in reduced diffusing capacity between patients with 
chronic heart failure and pulmonary venous congestion and Fontan patients with systemic 
venous congestion. 
The patients had signs of air trapping and this has also been shown in earlier studies (35, 36). 
This could be a result of several surgical procedures that leads to a restrictive lung physiology 
and non-ventilated lung sections peripherally. Ohuchi et al. (36) and Turquetto et al. (103) 
both suggest that the restrictive physiology and air trapping may limit exercise performance 
in these patients.  
An increase in vital capacity was seen in the patient group but not for the controls, after the 
exercise intervention. Thus, physical exercise might be beneficial for lung function in patients 
with Fontan circulation. Developed chest musculature may contribute to the increase in vital 
capacity in these patients, but more research is needed to clarify this. Regarding respiratory 
muscle training, Laohachai et al. (106) have demonstrated that it can increase muscle 
strength, result in more effective ventilation during exercise, and also increase resting cardiac 
output in Fontan patients. They proposed that physical exercise may improve exercise 
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performance and, in the long run, reduce morbidity and mortality. Ait Ali et al. (107) also 
showed that controlled respiratory training might improve cardiopulmonary performance 
during exercise in these patients. These studies support our results and speculations that 
physical exercise may improve chest musculature and vital capacity in our patient group. 
However, the clinical importance of the small but significant increase in vital capacity in the 
patient group is unclear. Quality of life was improved after this exercise intervention as well, 
as mentioned earlier, but it is difficult to argue which measured improvement of 
cardiopulmonary function, or other factor, that is the main factor contributing to an improved 
quality of life.  
Our results also suggest that maximal oxygen uptake is dependent on diffusing capacity (Fig 
11). This association has been presented before, in healthy subjects with different exercise 
capacities, by Zavorsky et al. (108). They reported that subjects with a high exercise capacity 
also had a high diffusing capacity and those with a lower exercise capacity, also had a lower 
diffusing capacity. Thus, Fontan patients’ reduced diffusing capacity may affect their 
maximal oxygen uptake and exercise capacity. Early palliative surgical procedures, to 
optimise pulmonary blood flow, can support lung growth and prevent permanent lung 
damage. Impaired lung function might affect physical performance and, thus, daily life during 
childhood and into adult life. 
Thus, children with Fontan circulation should engage in physical activities and sports in order 
to improve exercise capacity as well as lung function, and ultimately improve their quality of 
life. 
 
6.4 SLEEP AND EFFECTS OF EXERCISE (IV) 
A clinical problem, raised by the patients and their parents, is sleep disturbances of various 
types. Paper IV is the first study that analyses sleep in patients with Fontan circulation 
compared with healthy control subjects before and after an endurance training programme 
and after one year. Our results showed that patients with Fontan circulation have sleep 
duration and sleep efficiency similar to healthy children. The patients, however, had a 
prolonged latency to sleep onset compared with healthy control subjects. Also, we found that 
increased time in moderate-to-vigorous physical activity during daytime was positively 
correlated with increased sleep efficiency in the patient group, but not in the control group.   
Patients and controls met the recommended hours of sleep duration in both younger and older 
subjects (109). Moreover, our results showed a tendency for increasing age being associated 
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with decreased sleep efficiency in patients, but not in controls. Increased time in moderate-to-
vigorous physical activity during daytime was positively correlated with increased sleep 
efficiency in the patient group, but not in the control group, as mentioned earlier. Lang et al. 
(110) studied healthy adolescents and also showed that higher levels of physical activity were 
related to better subjective and objective sleep and sleep quality. In addition, Stone et al. 
(111) showed a positive relationship between physical activity and sleep duration in healthy 
children. Adolescents sleep shorter time and are less active than younger children, thus a 
model must adjust for age to avoid misleading results. As our patients and controls were 
matched for age and gender, we believe this risk was low in our study. More research is 
needed to better understand the mechanisms and relationship between amount of physical 
activity in daytime and sleep in patients with Fontan circulation. 
After endurance training, neither sleep duration nor sleep efficiency changed for patients or 
controls. Patients and controls with low sleep efficiency at baseline did, however, increase 
their sleep efficiency significantly more (p < 0.05) after the training programme than subjects 
with high sleep efficiency at baseline. Thus, it seems that subjects with low sleep efficiency 
benefits more from endurance training than subjects with higher sleep efficiency. Kredlow et 
al. (112) reviewed studies of effects of physical activity on sleep in adults and showed acute 
benefits of exercise on many sleep parameters, and also greater subjective and objective sleep 
benefits of regular exercise over longer time. Our training programmes may have been of 
suboptimal duration and/or intensity for maximal positive effects for our patients and more 
research is needed to understand the effects of exercise on sleep in this patient group 
compared with healthy children. 
Our patients and their parents reported a long recovery time after physical activity and fatigue 
the day after physical exercise. This is important to take into consideration and individually 
designed physical activities in schools and in the community should be available for children 
with complex congenital heart malformations to perhaps minimise these side effects. This is 
not offered in society today. 
At follow-up after one year, patients had decreased their total sleep time and sleep efficiency. 
These changes were not seen in the control group. Thus, patients and controls differed at 
follow-up after one year, which is concerning. Even though objectively measured activity did 
not change for patients or controls after training or at follow-up after one year, self-reported 
exercise decreased for patients, but not controls, at follow-up after one year. This could 
explain a worsening sleep pattern in the patient group over time. However, one cannot rule 
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out that worsening sleep patterns may have a negative impact on a child’s ability to engage in 
exercise and sports.  
To summarise, patients with Fontan circulation seem to have a prolonged latency to sleep 
onset compared with healthy children. Also, more time spent in physical activities of higher 
intensities seems to be beneficial for sleep quality in children with Fontan circulation. More 
research is needed to better understand the impact of and optimal regimens for exercise with 
regard to sleep and sleep quality in this patient group. 
 
6.5 CONTRAINDICATIONS / RISKS WITH EXERCISE 
There are, today, no absolute restrictions on physical activity for children and adults with 
congenital heart malformations. However, physical activity is not recommended if patients 
have acute illnesses, acute heart conditions or severe symptoms during exercise. Counselling 
regarding physical activity should always be individualised, since this is a heterogeneous 
group of patients with varying physical performances and risk factors. Patients with 
malignant arrhythmias and severely decreased systolic ventricular function, for example, are 
recommended to perform physical activities at lower intensities. Medications are common in 
this patient group. Betablockers can limit heart rate at rest and exercise. Anticoagulation can 
be a risk with sports that include body contact and individual counselling should be provided. 
Other heart medications are usually not regarded as added risks during exercise.  
The effects of physical exercise in patients with Fontan circulation are not fully understood. 
A review of effects of exercise training in children with various congenital heart diseases was 
performed by Duppen et al. (113) and they concluded that exercise was safe and improved 
fitness in these patient groups. In addition, Duppen et al. (114) have demonstrated that no 
adverse heart effects or cardiac remodelling were seen after exercise training in patients with 
Fontan circulation. They recommended that children with congenital heart disease, including 
patients with Fontan circulation, should participate in exercise training and that it should be 
part of the treatment of these patients. Long-term effects of exercise training in this patient 
group over longer time than one year have not been studied.  
 
6.7 STRENGTHS AND LIMITATIONS 
We studied 30 patients with Fontan circulation and the number of patients was limited by the 
Fontan cohort in the Stockholm region as presented under ‘Material’. The patients that joined 
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the study might represent a group of patients with better outcome than those who declined 
participation. We did not get ethical permission to analyse characteristics from patients who 
were excluded or declined participation in the study. The selection of control subjects can be 
argued, but we wanted to compare physical activity and quality of life in healthy children, 
who the patients are likely to compare themselves with. A matched control group for 
comparisons was considered important, in order to avoid comparisons with old reference 
material, since studies have shown a decline in physical activity and exercise performance in 
the general population over time (92, 93).  
The self-selected controls by the patients spent less time in physical activities and had a lower 
quality of life than the controls recruited by the research team, as described in Paper I. 
Moreover, compared with a Swedish reference material (87), the self-selected controls by the 
patients had lower PedsQL scores, while the controls recruited by the research team had 
similar PedsQL scores as the reference material. The controls recruited from hospital staff 
may be a group closer to the average levels of health consciousness and physically activity 
than the peers selected by the patients. 
Moreover, exercise interventions with other durations and/or other weekly frequencies could 
have resulted in other effects. The individually constructed training programmes aimed at 
improving compliance and, hopefully, giving greater chances for continued exercise even 
after one year in the study. Further studies are necessary to better understand the effects of 
exercise training among patients with Fontan circulation.  
We compared patients and a healthy control group before and after an exercise intervention 
and at follow-up after one year. More information on the impact of an exercise intervention 
could have been given if we had included a third study group, with patients who did only the 
three examinations at the same intervals, but without an exercise intervention. We felt, 
however, that it was important to include all patients in an intervention group because of the 
limited size of our Fontan cohort. 
Familiarisation with exercise and lung function testing is an important consideration when 
repeating tests. In our study, patients and controls performed identical examinations at the 
same intervals, enabling for comparisons to be made between the groups. 
Sleep among patients with Fontan circulation is a new field of research. Paper IV enlightens 
sleep patterns and impact of physical activity on sleep in this patient group. Exercise 
interventions with other duration, frequency, and/or intensity could have altered the results, 
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thus, more research is needed to find optimal regimens regarding exercise and its effect on 
sleep.  
Statistical analyses regarding gender differences and differences depending on anatomical 
ventricle have not been done to a larger extent because of the relative small patient number. 
More research is needed to clarify these aspects. 
 
7 CONCLUSIONS 
This thesis summarises our studies about effects of exercise training on cardiopulmonary 
function, sleep, and most importantly quality of life in patients with Fontan circulation 
compared with healthy controls.  
Children and adolescents with Fontan circulation reported less time in regular physical 
exercise than healthy controls, even though the objectively measured activity levels were 
similar between the groups. The patients and their parents also had a lower quality of life 
than the controls. Moreover, children with Fontan circulation have impaired physical 
performance and impaired lung function. Pulmonary diffusing capacity was reduced and 
the normal increase of diffusing capacity with age, seen in the healthy children, was not 
seen in the patients. Patients with Fontan circulation seem to have a prolonged latency to 
sleep onset compared with healthy children. Increased time in physical activities daytime 
seems to be correlated with better sleep quality in patients with Fontan circulation. 
Endurance training improved submaximal exercise capacity, pulmonary vital capacity, and 
quality of life but did not improve maximal exercise capacity in children with Fontan 
circulation. The improvement of quality of life was sustained at follow-up after one year.  
Thus, endurance training and/or increased amount of physical activity may improve 
submaximal exercise capacity, lung function, sleep quality, and quality of life in children 
and adolescents with Fontan circulation and the effect on quality of life seems to be long-
lasting. The clinical importance of our results is that if increased physical activity is likely 
to be beneficial for cardiopulmonary function, quality of life, and sleep, patients with 
Fontan circulation should be encouraged to engage in regular sports and activities that are 
individually designed. Rehabilitation programmes should include structured individualised 
endurance training for improved outcome in this patient group. Further research is 
necessary, however, to more fully understand the effects of exercise on cardiopulmonary 
function, sleep, and quality of life in this patient group. Also, further studies are needed on 
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how to individualise recommendations and find optimal regimens for exercise prescriptions 
for these patients. Moreover, research is needed to study long-term effects of exercise 
prescriptions in this patient group. The important message is, though, to encourage physical 
exercise and an active lifestyle in these patients for better health and well-being. 
 
8 CLINICAL UTILITY 
This thesis provides knowledge about the impact of physical activity and endurance training 
on cardiopulmonary function, sleep and quality of life on children and adolescents with 
Fontan circulation. Our results, showing that physical activity and endurance training can 
improve cardiopulmonary outcome, sleep efficiency, and quality of life for children and 
adolescents with Fontan circulation, should guide and strengthen families and care providers 
to encourage these children to be more physically active.  
 
9 FUTURE PERSPECTIVES 
More studies are needed to fully understand cardiopulmonary response to exercise, as well as 
its effects on sleep and on quality of life over a longer period of time in this patient group. We 
believe that exercise prescriptions should be individualised as regards type of exercise and 
recommended intensity through consultation with the child and his/her parents. Future studies 
should, however, focus on how to best individualise exercise prescriptions and how to 
implement exercise in rehabilitation programmes for patients with Fontan circulation for 
better outcome. Attempts have been made to formulate individual recommendations for adult 
patients with congenital heart disease, but these recommendations are based on limited 
clinical evidence (115). More research is needed on effects of different types of exercise 
training in patients with Fontan circulation and long-term benefits, as well as risks with 
different exercise regimens. 
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10 SVENSK SAMMANFATTNING 
 
Bakgrund 
Överlevnaden hos barn med kirurgiskt pallierat enkammarhjärta, s.k. Fontancirkulation, har 
ökat under de senaste decennierna. Idag överlever de flesta till vuxen ålder tack vare 
utvecklade kirurgiska tekniker och det medicinska omhändertagandet. Dessa barns fysiska 
prestationsförmåga och livskvalitet blir påverkade på sikt. Det saknas kunskap om effekter 
av fysisk träning på hjärt- och lungfunktion och livskvalitet i denna patientgrupp jämfört 
med friska barn. 
Syfte 
Syftet med denna avhandling var att studera fysisk aktivitet, fysisk kapacitet, lungfunktion, 
sömn och livskvalitet före och efter en träningsintervention samt efter 1 år, hos barn med 
kirurgiskt pallierat enkammarhjärta och en frisk ålders- och könsmatchad kontrollgrupp. Vi 
ville utvärdera om fysisk träning kunde förbättra hjärt- och lungfunktionen men även 
livskvaliteten, på kort och lång sikt i denna patientgrupp. 
Metoder 
Patienter med kirurgiskt pallierat enkammarhjärta (n = 30) och friska kontroller (n = 25) 
genomförde tester av fysisk aktivitet, submaximal och maximal prestationsförmåga, 
lungfunktion, sömn och livskvalitet före och efter ett individuellt anpassat träningsprogram 
om 12 veckor, samt efter 1 år. 
Resultat 
Barn med kirurgiskt pallierat enkammarhjärta rapporterade mindre tid i organiserad fysisk 
aktivitet och lägre livskvalitet jämfört med friska kontroller. Den objektivt uppmätta totala 
aktiviteten var dock lika i båda grupperna. Barn med kirurgiskt pallierat enkammarhjärta 
hade nedsatt fysisk prestationsförmåga, restriktivt andningsmönster och nedsatt 
diffusionskapacitet (gasutbyte i lungorna). Den förväntade ökningen av diffusionskapacitet 
med ålder skiljde sig från den normala hos patienterna. Fysisk träning förbättrade den 
submaximala prestationsförmågan och livskvaliteten, men inte den maximala 
prestationsförmåga hos hjärtbarnen. Vid uppföljningen efter 1 år hade den submaximala 
prestationsförmågan förbättrats ytterligare och den förbättrade livskvaliteten bestod. Fysisk 
träning förbättrade också vitalkapaciteten vid lungfunktionstester.  
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Barn med kirurgiskt pallierat enkammarhjärta hade en förlängd insomningstid jämfört med 
friska barn. Ökad tid i fysiska aktiviteter av högre intensitet var korrelerat med bättre 
sömnkvalitet hos hjärtbarnen.  
Slutsatser 
Individuellt anpassade träningsprogram verkar kunna förbättra submaximal 
prestationsförmåga, lungfunktion och livskvalitet hos barn med kirurgiskt pallierat 
enkammarhjärta och förbättringen av livskvalitet håller i sig på lång sikt. Ökad tid i fysiska 
aktiviteter med högre intensitet verkar gynnsamt för sömnkvaliteten hos dessa barn. Om ökad 
fysisk aktivitet och fysisk träning är gynnsamt för hjärt- och lungfunktion, sömn och 
livskvalitet borde dessa barn bli uppmuntrade att delta i regelbunden individuellt anpassad 
fysisk träning. Rehabiliteringsprogram borde innehålla tydliga rekommendationer och 
strukturerad anpassad träning. Fler studier behövs för att bättre kartlägga och förstå effekter 
av olika typer av fysisk träning på hjärt- och lungfunktion och livskvalitet i denna 
patientgrupp både på kort och lång sikt. Fler studier behövs också om hur man på bästa sätt 
kan individualisera rekommendationer för träning i denna patientgrupp. Fysisk träning och 
fysisk aktivitet bör dock redan nu uppmuntras hos dessa patienter för ökat välbefinnande. 
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